Mesoblast MESO
NASDAQ MESO
$17.32 +0.18 (+1.05%)
At close: Sep 4, 2026 · 4:00 PM EDT

Mesoblast (MESO) Short term Debt (2018 - 2026)

Mesoblast (MESO) posted Short term Debt of $66.7 million for Q4 2025, down 1.48% sequentially from $67.7 million in Q2 2025, and down 34.23% YoY from $101.5 million in Q4 2024.

Analysis

Mesoblast (MESO) Short term Debt (2018 - 2026) Analysis & Trends

Mesoblast has reported Short term Debt for 8 years, with the latest figure at $66.7 million in Q4 2025.

  • Quarterly Short term Debt fell 34.23% year-over-year to $66.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $66.7 million (down 34.23% YoY) and the FY2025 annual result came in at $67.7 million, up 388.67% from the prior year.
  • Short term Debt declined to $66.7 million in Q4 2025 per MESO's latest filing, from $67.7 million in the prior quarter.
  • Over five years, Short term Debt peaked at $107.2 million in Q4 2023 and troughed at $5.0 million in Q2 2022.
  • A 5-year average of $67.1 million and a median of $77.1 million in 2021 frame the typical range for Short term Debt.
  • The sharpest annual moves came in 2022 and 2025: Short term Debt sank 90.57% in 2022, then jumped 388.67% in 2025.
  • Over 5 years, Short term Debt stood at $86.5 million in 2021, then grew by 12.07% to $97.0 million in 2022, then grew by 10.56% to $107.2 million in 2023, then declined by 5.37% to $101.5 million in 2024, then plunged by 34.23% to $66.7 million in 2025.
  • According to Business Quant data, Short term Debt over the past three periods registered $66.7 million, $67.7 million, and $101.5 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Mesoblast 2.24 Bn 2.14 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 10.60 Mn
Dec 31, 2025 66.74 Mn
Jun 30, 2025 54.16 Mn
Dec 31, 2024 17.51 Mn
Jun 30, 2024 13.86 Mn
Dec 31, 2023 8.53 Mn
Jun 30, 2023 5.95 Mn
Mar 31, 2023 7.31 Mn
Dec 31, 2022 5.94 Mn
Sep 30, 2022 5.49 Mn
Jun 30, 2022 5.02 Mn
Mar 31, 2022 5.52 Mn
Dec 31, 2021 5.20 Mn
Sep 30, 2021 53.85 Mn
Jun 30, 2021 53.20 Mn
Mar 31, 2021 52.67 Mn
Dec 31, 2020 41.57 Mn
Sep 30, 2020 34.89 Mn
Jun 30, 2020 32.46 Mn
Mar 31, 2020 27.00 Mn